LILLY FDA Approval ANDA 062590

ANDA 062590

LILLY

FDA Drug Application

Application #062590

Application Sponsors

ANDA 062590LILLY

Marketing Status

Discontinued001
Discontinued002

Application Products

001INJECTABLE;INTRAVENOUSEQ 750MG BASE/VIAL0KEFUROX IN PLASTIC CONTAINERCEFUROXIME SODIUM
002INJECTABLE;INJECTIONEQ 1.5GM BASE/VIAL0KEFUROX IN PLASTIC CONTAINERCEFUROXIME SODIUM

FDA Submissions

ORIG1AP1986-01-10
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1986-10-30
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1992-06-12
LABELING; LabelingSUPPL8AP1992-06-12
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1993-04-14

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL5Null0
SUPPL9Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62590
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.